CIK: 0000903603 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 11, 2022
Total Value ($000): $269,733 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LNWO | LIGHT AND WONDER | 1,785,714 | $83,911 | 31.1% | $36.83 | +45.3% | COM | 80874P109 |
| CPNG | COUPANG INC | 6,126,664 | $78,115 | 29.0% | $30.21 | -54.9% | CL A | 22266T109 |
| NU | NU HLDGS LTD | 13,938,154 | $52,129 | 19.3% | $5.07 | 0.0% | ORD SHS CL A | G6683N103 |
| MRNA | MODERNA INC | 150,000 | $21,428 | 7.9% | $178.71 | -20.0% | COM | 60770K107 |
| GWRE | GUIDEWIRE SOFTWARE INC | 281,689 | $19,997 | 7.4% | $114.12 | -28.3% | COM | 40171V100 |
| — | MELI KASZEK PIONEER CORP | 700,000 | $6,930 | 2.6% | $11.05 | — | CLASS A ORD | G5S74L106 |
| — | VACASA INC | 1,361,470 | $3,921 | 1.5% | $2.88 | — | CLASS A COM | 91854V107 |
| — | GINKGO BIOWORKS HOLDINGS INC | 1,102,044 | $2,623 | 1.0% | $4.03 | — | CL A SHS | 37611X100 |
| — | NGM BIOPHARMACEUTICALS INC | 44,314 | $568 | 0.2% | $12.82 | — | COM | 62921N105 |
| — | CNFINANCE HOLDINGS LTD ADR | 26,509 | $68 | 0.0% | $5.90 | — | SPON ADS | 18979T105 |
| — | MERSANA THERAPEUTICS INC | 9,367 | $43 | 0.0% | $4.59 | — | COM | 59045L106 |